僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant （DOAC）. Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis